Featured news


 Manganese exploration company Black Canyon (ASX:BCA) earns 75% interest in the Carawine JV

Manganese exploration company Black Canyon (ASX:BCA) earns 75% interest in the Carawine JV

January 09, 2023 12:01 PM AEDT| By Team Kalkine Media

Highlights:,Black Canyon has earned 75% interest in the Carawine Joint Venture after the Company satisfied the commitment of AU $4 million expenditure.,Black Canyon has made significant progress over the Joint Venture portfolio, specifically at Flana...

 Imugene (ASX:IMU) gets ethics approval for phase 1 VAXINIA trial in Australia

Imugene (ASX:IMU) gets ethics approval for phase 1 VAXINIA trial in Australia

January 09, 2023 11:26 AM AEDT| By Manisha

A clinical-stage immuno-oncology company, Imugene Limited (ASX:IMU), has won Human Research Ethics Committee (HREC) approval to start Phase I clinical trial of its oncolytic virotherapy candidate, VAXINIA, in Australia.

 Inside Surefire Resources’ (ASX:SRN) 2022 developments at WA exploration assets

Inside Surefire Resources’ (ASX:SRN) 2022 developments at WA exploration assets

January 05, 2023 01:42 PM AEDT| By Ankur Jaiswal

Highlights:,The year 2022 has been a very busy period for Surefire (ASX:SRN), which executed a gamut of exploration and development activities across its diversified mineral project portfolio,Metallurgical test work at the Yidby Gold Project delivere...

 QX Resources (ASX:QXR) on track to develop its high-valued lithium projects

QX Resources (ASX:QXR) on track to develop its high-valued lithium projects

January 05, 2023 01:18 PM AEDT| By Ankur Jaiswal

Highlights:,QX Resources (ASX:QXR) holds highly prospective lithium assets in Western Australia.,The projects sit in strategic proximity to some of Australia’s largest lithium deposits.,A maiden RC drilling program was undertaken at the Turner River...

 Key FYI Resources’ (ASX:FYI) developments that you might have missed in 2022

Key FYI Resources’ (ASX:FYI) developments that you might have missed in 2022

January 05, 2023 11:20 AM AEDT| By Ankur Jaiswal

Highlights:,2022 has been a very busy period for FYI Resources, which undertook significant developments focused on its world-class integrated high-purity alumina (HPA) project,FYI believes that downstream opportunities can create additional value-ad...

 Invion (ASX:IVX) scales heights in cancer and infectious disease research in 2022

Invion (ASX:IVX) scales heights in cancer and infectious disease research in 2022

January 05, 2023 11:11 AM AEDT| By Aditi Sarkar

Highlights,Invion witnessed successful research outcomes in 2022, laying the groundwork for an exciting 2023,The combination therapy of the company’s lead candidate INV043 with ICI therapy resulted in a nearly 65% reduction in tumour size in mice com...

 Lithium Australia (ASX:LIT) welcomes new CEO, powers ahead in battery tech space

Lithium Australia (ASX:LIT) welcomes new CEO, powers ahead in battery tech space

January 04, 2023 04:48 PM AEDT| By Ankur Jaiswal

Highlights:,Lithium Australia’s (ASX:LIT) new CEO Simon Linge officially started with the company on 1 January 2023,2022 saw LIT’s transition from a no liability company to a limited liability company, with its classification updated from exploration...

 Learn how MediKane's NutriKane D helps in blood sugar level management

Learn how MediKane's NutriKane D helps in blood sugar level management

January 04, 2023 12:22 PM AEDT| By Aditi Sarkar

Highlights,NutriKane D is a plant-based food in the form of powder that helps lower and maintain the blood glucose level,Fibres in NutriKane D are not heavily processed retaining nutrients and waxes naturally occurring within the plants,Trials of Nut...

 What makes IOUpay (ASX:IOU) a formidable fintech player in South East Asia?

What makes IOUpay (ASX:IOU) a formidable fintech player in South East Asia?

January 04, 2023 11:16 AM AEDT| By Ankit Sethi

Highlights,ASX-listed IOUpay is a fintech player in Malaysia, with planned expansion into other SEA market jurisdictions,Major initiatives in the recent past include upgraded BNPL offering, Shariah-compliant payments system, myIOU Business+ and a sle...

 Invictus (ASX:IVZ) secures rig contract extension for a year in Cabora Bassa Basin

Invictus (ASX:IVZ) secures rig contract extension for a year in Cabora Bassa Basin

January 03, 2023 11:50 AM AEDT| By Manisha

Highlights,Invictus Energy (ASX:IVZ) and Exalo Drilling S.A have agreed upon a contract amendment for Rig 202 to remain in the Cabora Bassa Basin for another 12 months.,Log analysis indicates multiple potential gas bearing reservoir units.,According...

 Boab Metals (ASX:BML) gets impressive initial Phase VI drill assays for Sorby Hills

Boab Metals (ASX:BML) gets impressive initial Phase VI drill assays for Sorby Hills

December 30, 2022 03:05 PM AEDT| By Team Kalkine Media

Highlights:,The first set of assays from the recently completed Phase VI drilling has boosted Boab Metals’ confidence in its Sorby Hills Lead-Silver-Zinc Project.,The assays from the Beta Deposit have validated the current mineralisation model, openi...

 Radiopharm (ASX:RAD) shares jump on FDA IND approval for RAD301 technology

Radiopharm (ASX:RAD) shares jump on FDA IND approval for RAD301 technology

December 30, 2022 02:55 PM AEDT| By Aditi Sarkar

Highlights,Radiopharm has secured IND approval from the US FDA for its αVβ6 Integrin (RAD301) technology.,The IND approval enables the company to commence a Phase 1 imaging trial at the end of Q1 CY23.,The company believes that the technology will de...

 Invictus (ASX:IVZ) reports multiple potential gas bearing zones at Mukuyu-1 sidetrack well

Invictus (ASX:IVZ) reports multiple potential gas bearing zones at Mukuyu-1 sidetrack well

December 29, 2022 11:43 AM AEDT| By Manisha

Highlights,Invictus Energy (ASX:IVZ) has shared encouraging results from preliminary wireline program at the Mukuyu-1 ST1 well.,As per log analysis, there are numerous potential gas bearing reservoir units at the wellsite.,The company will soon resum...

 Inside Invion’s (ASX:IVX) quest to tap multi-billion-dollar opportunity in viral disease treatment space

Inside Invion’s (ASX:IVX) quest to tap multi-billion-dollar opportunity in viral disease treatment space

December 28, 2022 10:45 AM AEDT| By Aditi Sarkar

Highlights,The world needs to focus on developing innovative treatments to be prepared for the next pandemic,Invion’s research on Photosoft,TM,compounds has demonstrated effectiveness against dengue, the Zika virus and COVID-19 variants,Market studie...

 Why EPC service provider Saunders’ 2022 developments are so important (ASX:SND)

Why EPC service provider Saunders’ 2022 developments are so important (ASX:SND)

December 23, 2022 04:07 PM AEDT| By Ankur Jaiswal

Highlights:,2022 has been a very busy period for Saunders, with a number of significant multi-million-dollar contracts wins during the year,These contracts hold strategic importance, fuelling Australian industries’ development and boosting the compan...

 Cyprium (ASX:CYM) eyes Nifty restart with US$35M copper cathode offtake secured prepayment facility

Cyprium (ASX:CYM) eyes Nifty restart with US$35M copper cathode offtake secured prepayment facility

December 23, 2022 11:13 AM AEDT| By Ankur Jaiswal

Highlights,:,Cyprium Metals’ (ASX:CYM) shares soared over 30% on a new arrangement with Transamine SA.,The term sheet is in respect of a copper cathode offtake secured prepayment facility.,The offtake prepayment facility is part of a debt funding pac...

 Musgrave (ASX:MGV) wraps up SPP, raises AU$2.117 million for the Cue Gold Project

Musgrave (ASX:MGV) wraps up SPP, raises AU$2.117 million for the Cue Gold Project

December 22, 2022 06:22 PM AEDT| By Aditi Sarkar

Highlights,Musgrave Minerals has completed its Share Purchase Plan (SPP) raising AU$2,117,000.,Musgrave raised AU$2,117,000 through the SPP.,The Company recently raised AU$8,000,000 through Placement to sophisticated and institutional investors.,The...

 Chimeric (ASX:CHM) advances CHM 1101 clinical trial with dosing completion in third dose cohort

Chimeric (ASX:CHM) advances CHM 1101 clinical trial with dosing completion in third dose cohort

December 22, 2022 12:22 PM AEDT| By Aditi Sarkar

Highlights,Chimeric has completed dosing in the 3rd dose cohort in Phase 1 clinical trial of CHM 1101 (CLTX CAR T) cell therapy.,The objective of the Phase 1 trial is to assess the safety and effectiveness of CLTX CAR T and to determine the suggested...

 How this small-cap ASX biotech bolstered its cancer leadership position in 2022

How this small-cap ASX biotech bolstered its cancer leadership position in 2022

December 22, 2022 10:55 AM AEDT| By Aditi Sarkar

Highlights,Prescient marked a number of developments in 2022, cementing its lead in cancer therapy innovation.,PTX-100, being studied in a type of rare blood cancer, continued to demonstrate encouraging clinical activity with a very favourable safety...

 Raiden (ASX:RDN) lands further strong Ni-Cu-PGE assays, eyes Mt Sholl resource modelling in early Q1

Raiden (ASX:RDN) lands further strong Ni-Cu-PGE assays, eyes Mt Sholl resource modelling in early Q1

December 21, 2022 01:27 PM AEDT| By Ankur Jaiswal

Highlights:,Raiden Resources (ASX:RDN) has unveiled high-grade & broad zones of Ni-Cu-PGE sulphide mineralisation from the last set of assays.,The company completed a total of 39 diamond holes for 4,204m at Mt Sholl.,The results continue to correlate...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.